Vyne Therapeutics Inc (NASDAQ:VYNE)

0.2232
Delayed Data
As of 1:59pm ET
 -0.0061 / -2.66%
Today’s Change
0.22
Today|||52-Week Range
1.75
-78.12%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Domzalski David
President & Chief Executive Officer
Sale3/31/202223,186$0.65$15.1K-64.73%
Domzalski David
President & Chief Executive Officer
Sale12/31/20216,887$1.02$7.0K-77.52%
Domzalski David
President & Chief Executive Officer
Sale6/30/202210,683$0.39$4.2K-41.04%
Harsch Mutya
Sale3/31/20223,630$0.65$2.4K-64.73%
Domzalski David
President & Chief Executive Officer
Sale9/30/202210,683$0.22$2.4K+2.78%
Stuart Iain A
Chief Scientific Officer
Sale3/31/20223,469$0.65$2.3K-64.73%
Harsch Mutya
Sale12/31/20211,484$1.02$1.5K-77.52%
Stuart Iain A
Chief Scientific Officer
Sale12/31/20211,250$1.02$1.3K-77.52%
Harsch Mutya
Sale6/30/20221,813$0.39$707.07-41.04%
Stuart Iain A
Chief Scientific Officer
Sale6/30/20221,719$0.39$670.41-41.04%
Page of 2